FdaApplication

ANDA 216751

Back to search

Identifiers

Properties

PropertyValue
applicant_namePRASCO LLC DBA PRASCO LABORATORIES
application_typeANDA
approval_date2023-01-18

Products (4)

ProductActive ingredientStrengthDosage form
MIRTAZAPINEMIRTAZAPINE7.5MGTABLET;ORAL
MIRTAZAPINEMIRTAZAPINE45MGTABLET;ORAL
MIRTAZAPINEMIRTAZAPINE15MGTABLET;ORAL
MIRTAZAPINEMIRTAZAPINE30MGTABLET;ORAL

4 products